Level Four Advisory Services’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.04M | Sell |
4,319
-99
| -2% | -$49.8K | 0.07% | 285 |
|
|
2025
Q4 | $2.06M | Buy |
4,418
+1,828
| +71% | +$849K | 0.07% | 280 |
|
|
2025
Q3 | $1.1M | Buy |
2,590
+66
| +3% | +$25.6K | 0.04% | 387 |
|
|
2025
Q2 | $967K | Buy |
2,524
+25
| +1% | +$9.01K | 0.04% | 386 |
|
|
2025
Q1 | $864K | Buy |
2,499
+113
| +5% | +$36.3K | 0.04% | 384 |
|
|
2024
Q4 | $716K | Sell |
2,386
-161
| -6% | -$56.3K | 0.03% | 424 |
|
|
2024
Q3 | $914K | Sell |
2,547
-314
| -11% | -$115K | 0.04% | 379 |
|
|
2024
Q2 | $919K | Buy |
2,861
+403
| +16% | +$131K | 0.04% | 354 |
|
|
2024
Q1 | $665K | Hold |
2,458
| – | – | 0.04% | 386 |
|
|
2023
Q4 | $665K | Buy |
2,458
+248
| +11% | +$61.3K | 0.04% | 380 |
|
|
2023
Q3 | $544K | Hold |
2,210
| – | – | 0.04% | 423 |
|
|
2023
Q2 | $671K | Sell |
2,210
-315
| -12% | -$87.6K | 0.04% | 392 |
|
|
2023
Q1 | $666K | Buy |
2,525
+69
| +3% | +$17.5K | 0.04% | 361 |
|
|
2022
Q4 | $589K | Buy |
2,456
+618
| +34% | +$138K | 0.04% | 361 |
|
|
2022
Q3 | $338K | Buy |
1,838
+72
| +4% | +$14.3K | 0.03% | 400 |
|
|
2022
Q2 | $297K | Sell |
1,766
-135
| -7% | -$29K | 0.03% | 450 |
|
|
2022
Q1 | $476K | Buy |
1,901
+21
| +1% | +$5.27K | 0.04% | 407 |
|
|
2021
Q4 | $483K | Sell |
1,880
-219
| -10% | -$53.6K | 0.04% | 395 |
|
|
2021
Q3 | $509K | Buy |
2,099
+175
| +9% | +$42.8K | 0.05% | 285 |
|
|
2021
Q2 | $398K | Sell |
1,924
-82
| -4% | -$16.7K | 0.03% | 463 |
|
|
2021
Q1 | $378K | Buy |
2,006
+145
| +8% | +$25.6K | 0.03% | 450 |
|
|
2020
Q4 | $306K | Sell |
1,861
-49
| -3% | -$7.17K | 0.02% | 462 |
|
|
2020
Q3 | $238K | Sell |
1,910
-322
| -14% | -$39.9K | 0.02% | 484 |
|
|
2020
Q2 | $219K | Buy |
+2,232
| New | +$232K | 0.02% | 516 |
|
|
2020
Q1 | – | Sell |
-1,801
| Closed | -$267K | – | 515 |
|
|
2019
Q4 | $267K | Buy |
1,801
+101
| +6% | +$13.6K | 0.01% | 485 |
|
|
2019
Q3 | $205K | Buy |
1,700
+32
| +2% | +$4.13K | 0.02% | 475 |
|
|
2019
Q2 | $225K | Hold |
1,668
| – | – | 0.02% | 473 |
|
|
2019
Q1 | $217K | Sell |
1,668
-728
| -30% | -$97.8K | 0.02% | 469 |
|
|
2018
Q4 | $298K | Buy |
+2,396
| New | +$322K | 0.04% | 400 |
|
|
2017
Q3 | – | Sell |
-5,332
| Closed | -$472K | – | 513 |
|
|
2017
Q2 | $472K | Sell |
5,332
-3,626
| -40% | -$307K | 0.07% | 273 |
|
|
2017
Q1 | $794K | Sell |
8,958
-1,909
| -18% | -$159K | 0.08% | 244 |
|
|
2016
Q4 | $804K | Buy |
+10,867
| New | +$814K | 0.1% | 197 |
|
Other funds holding HCA
VCM
VPM
Level Four Advisory Services's HCA Position: Q1 2026 in Review
Level Four Advisory Services reduced its HCA Healthcare (HCA) stake by 2.2% in Q1 2026, selling an estimated $49.8K and leaving 4,319 shares worth $2.04M. The position accounts for 0.07% of the portfolio, ranked #285.
Level Four Advisory Services first reported a position in HCA in Q4 2016 and has held it in 32 quarters since. The position peaked at $2.06M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Level Four Advisory Services held 4,319 shares of HCA Healthcare worth $2.04M as of Q1 2026.
- Level Four Advisory Services sold 99 HCA Healthcare shares in Q1 2026, an estimated $49.8K.
- HCA Healthcare made up 0.07% of Level Four Advisory Services's portfolio in Q1 2026, its #285 holding.
- Level Four Advisory Services first reported a position in HCA Healthcare in Q4 2016 and has held it in 32 quarters since.
- Level Four Advisory Services's HCA Healthcare position peaked at $2.06M in Q4 2025.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.